Live Breaking News & Updates on Regenxbio Inc

Stay updated with breaking news from Regenxbio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

REGENXBIO (NASDAQ:RGNX) Stock Price Down 5%

REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report)’s stock price traded down 5% on Monday . The stock traded as low as $13.22 and last traded at $13.38. 322,961 shares were traded during trading, a decline of 48% from the average session volume of 622,212 shares. The stock had previously closed at $14.08. Analyst Ratings Changes […] ....

Canada , China , United-states , Raymond-james , Robertw-baird , Technology-platform , Regenxbio-inc , Goldman-sachs-group , China-universal-asset-management-co , Nasdaq , Royal-bank , Annandale-capital

Head to Head Contrast: Rocket Pharmaceuticals (NASDAQ:RCKT) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT)

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) and Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Earnings & Valuation This table compares […] ....

United-states , California , Sweden , New-jersey , Cranbury , Stockholm , Fundacion-jimenez-diaz , Investigacion-biomedica , Medioambientalesy-tecnol , Investigaciones-energ , Regenxbio-inc , Rocket-pharmaceuticals-inc

Head-To-Head Analysis: Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and Rocket Pharmaceuticals (NASDAQ:RCKT)

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Rocket Pharmaceuticals […] ....

United-states , Stockholm , Sweden , California , Cranbury , New-jersey , Medioambientalesy-tecnol , Investigacion-biomedica , Investigaciones-energ , Fundacion-jimenez-diaz , Rocket-pharmaceuticals , Nasdaq

Leerink Partnrs Weighs in on REGENXBIO Inc.'s Q2 2024 Earnings (NASDAQ:RGNX)

REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Investment analysts at Leerink Partnrs dropped their Q2 2024 earnings per share (EPS) estimates for shares of REGENXBIO in a research report issued to clients and investors on Wednesday, May 8th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will earn ($1.19) per share for […] ....

Canada , United-states , China , Stifel-nicolaus , Leerink-partnrs , Steve-pakola , Allspring-global-investments-holdings , Headlands-technologies , Securities-exchange-commission , China-universal-asset-management-co , Regenxbio-inc , Financial-services-group-inc

Q2 2024 EPS Estimates for REGENXBIO Inc. (NASDAQ:RGNX) Cut by Leerink Partnrs

REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Stock analysts at Leerink Partnrs dropped their Q2 2024 earnings per share estimates for REGENXBIO in a research note issued on Wednesday, May 8th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will post earnings of ($1.19) per share for the quarter, down from their […] ....

Canada , United-states , China , Steve-pakola , Leerink-partnrs , Stifel-nicolaus , Allspring-global-investments-holdings , Headlands-technologies , China-universal-asset-management-co , Financial-services-group-inc , Barclays , Regenxbio-inc